These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16310759

  • 1. Practical considerations in PTH testing.
    Souberbielle JC, Friedlander G, Cormier C.
    Clin Chim Acta; 2006 Apr; 366(1-2):81-9. PubMed ID: 16310759
    [Abstract] [Full Text] [Related]

  • 2. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG.
    Blood Purif; 2003 Apr; 21(1):118-23. PubMed ID: 12596757
    [Abstract] [Full Text] [Related]

  • 8. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
    Gannagé-Yared MH, Farès C, Ibrahim T, Rahal ZA, Elias M, Chelala D.
    Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
    [Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T, Ishida M, Fukagawa M.
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.